Webb15 feb. 2024 · The aim of the study is to determine the impact of a restrictive fluids strategy (vasopressors first followed by rescue fluids) as compared to a liberal fluid strategy (fluids first followed by rescue vasopressors) on 90-day in-hospital mortality in patients with sepsis-induced hypotension. Detailed Description: Webb6 dec. 2024 · [email protected] OHSU flame logo in white Oregon Health & Science University is dedicated to improving the health and quality of life for all Oregonians …
SpHincterotomy for Acute Recurrent Pancreatitis (SHARP)
Webb3 juli 2024 · The SHARP study was supported by funding from the Alzheimer’s Association and performed out of OHSU’s Layton Aging & Alzheimer’s Disease Center, one of the National Institute of Health’s top ranked facilities of such research. The original pilot program, which launched in 2016, was supported by the U.S. Centers for Disease Control … Webb1 apr. 2011 · Description. DESCRIPTION (provided by applicant): The Oregon Brain Aging Study (OBAS) is a longitudinal study of factors related to healthy brain aging in the oldest old (those e age 85), the fastest growing segment of the population and those at highest risk for dementia. During the past 20 years the OBAS has examined the trajectory and ... cst pis cofins 51
Antibody Response and Variant Cross-Neutralization After SARS
WebbOHSU has a long history of excellence in cardiovascular care and innovation: from the first shaped coronary catheters by Judkins and first mechanical prosthetic valve by Starr, to the first peripheral angioplasty by Dotter. We are also pleased to announce that OHSU has recently been accredited for an Interventional Cardiology Fellowship. Webb19 mars 2024 · (OHSU/Kristyna Wentz-Graff) Right now, Gene Gilmer is as sharp as ever at 90 years of age. A retired school superintendent who earned his doctorate in math decades ago, Gilmer lives alone and worries about losing the memories that defined his life. That’s part of the reason he enrolled in an unusual clinical trial through OHSU in Portland, Oregon. Webb30 nov. 2010 · The Study of Heart and Renal Protection (SHARP) involved about 9,400 volunteers aged 40 or over with chronic kidney disease recruited from 380 hospitals in 18 countries. Patients included in the trial had lost at least 50% of their normal kidney function, with a third of them requiring dialysis treatment. cst pit kirson 26